Clinical Trial Update: Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction [Phase 4]

View source ↗

Summary

This clinical trial update concerns the planned Phase 4 study of Vevye Ophthalmic Solution for Meibomian gland dysfunction. Recruitment has not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meibomian Gland Dysfunction

Drugs mentioned

• Vevye Ophthalmic Solution

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Meibomian Gland Dysfunction (MGD) | Phase 4 | Status: NOT_YET_RECRUITING